Trends of Prescription Drug Manufacturer Rebates in Commercial Health Insurance Plans, 2015-2019.
cross_sectional · Level IV
Where this comes from
- Record sourced from PubMed, PMID 35977258.
- Also identified by DOI 10.1001/jamahealthforum.2022.0888 and PMC identifier 9077484.
- Licence recorded as CC BY.
- The licence permits redistribution, so the abstract is shown in full and the full text is available from the publisher.
Abstract
This economic evaluation examines the magnitude and trend of prescription drug rebates in commercial markets from 2015 to 2019 and identifies insurance plan factors associated with rebates.
Medical subject headings
- Prescription Drugs